| 000 | 01810 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514004511.0 | ||
| 264 | 0 | _c20010816 | |
| 008 | 200108s 0 0 eng d | ||
| 022 | _a0022-2615 | ||
| 024 | 7 |
_a10.1099/0022-1317-50-8-682 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDemertzi, E | |
| 245 | 0 | 0 |
_aCharacterisation of VanA and VanB elements from glycopeptide-resistant Enterococcus faecium from Greece. _h[electronic resource] |
| 260 |
_bJournal of medical microbiology _cAug 2001 |
||
| 300 |
_a682-687 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aBacterial Proteins _xclassification |
| 650 | 0 | 4 |
_aCarbon-Oxygen Ligases _xclassification |
| 650 | 0 | 4 | _aDeoxyribonucleases, Type II Site-Specific |
| 650 | 0 | 4 |
_aDrug Resistance, Microbial _xgenetics |
| 650 | 0 | 4 | _aElectrophoresis, Gel, Pulsed-Field |
| 650 | 0 | 4 |
_aEnterococcus faecium _xdrug effects |
| 650 | 0 | 4 | _aGene Amplification |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aGreece |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 | _aMultigene Family |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aPoint Mutation |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 | _aPolymorphism, Restriction Fragment Length |
| 650 | 0 | 4 |
_aRectum _xmicrobiology |
| 650 | 0 | 4 |
_aTeicoplanin _xpharmacology |
| 650 | 0 | 4 |
_aVancomycin Resistance _xgenetics |
| 700 | 1 | _aPalepou, M-F I | |
| 700 | 1 | _aKaufmann, M E | |
| 700 | 1 | _aAvlamis, A | |
| 700 | 1 | _aWoodford, N | |
| 773 | 0 |
_tJournal of medical microbiology _gvol. 50 _gno. 8 _gp. 682-687 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1099/0022-1317-50-8-682 _zAvailable from publisher's website |
| 999 |
_c11405898 _d11405898 |
||